Sales rise 0.48% to Rs 454.33 crore
Net profit of Nectar Lifescience rose 399.36% to Rs 7.84 crore in the quarter ended December 2024 as against Rs 1.57 crore during the previous quarter ended December 2023. Sales rose 0.48% to Rs 454.33 crore in the quarter ended December 2024 as against Rs 452.16 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales454.33452.16 0 OPM %9.849.33 -PBDT28.1617.83 58 PBT12.552.46 410 NP7.841.57 399Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
